Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | NT5E | P21589 | 1/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.75 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.73 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.71 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.69 |
| ▸ | DPP4 | P27487 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.69 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.69 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.69 |
| ▸ | GAPDH | P04406 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | STAT6 | P42226 | 1/20 | 0.69 |
| ▸ | PI4KA | P42356 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.69 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7038406 | 1.00 | LMNA (0.75) | LMNANT5EHIF1AADORA2AADORA2B | |
| Phosphoric Acid SCHEMBL21465159 | 0.94 | LMNA (0.68) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL8333120 | 0.91 | LMNA (0.61) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL8333122 | 0.91 | LMNA (0.61) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL8923023 | 0.90 | ADORA2A (0.77) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL8923008 | 0.90 | ADORA2A (0.77) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL24359132 | 0.88 | LMNA (0.78) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL16579288 | 0.88 | LMNA (0.78) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL10176676 | 0.88 | LMNA (0.78) | LMNANT5EHIF1AADORA2AADORA2B | |
| SCHEMBL22559823 | 0.88 | LMNA (0.78) | LMNANT5EHIF1AADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 600 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0763049-B1 | NUCLEOSIDE MONOPHOSPHATE DERIVATIVES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS IMMUNOSUPPRESSIVE DRUGS | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2003-04-02 | — | — | EP | claimed |
| US-6025343-A | Lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs | ROCHE DIAGNOSTICS GMBH (DE) | 2000-02-15 | — | — | US | claimed |
| EP-0763049-A1 | NEW LIPID ESTERS OF NUCLEOSIDE MONOPHOSPHATES AND THEIR USE AS IMMUNOSUPPRESSIVE DRUGS | Roche Diagnostics GmbH (DE) | 1997-03-19 | — | — | EP | claimed |
| WO-1995032984-A1 | NEW LIPID ESTERS OF NUCLEOSIDE MONOPHOSPHATES AND THEIR USE AS IMMUNOSUPPRESSIVE DRUGS | BOEHRINGER MANNHEIM GMBH (DE) | 1995-12-07 | — | — | WO | claimed |
| JP-54061195-A | — | — | None | — | — | JP | disclosed |
| EP-4746905-A1 | RSV VACCINE | Astrazeneca AB (SE) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026106956-A1 | DISULFIDE-STABILIZED NOROVIRUS VIRUS-LIKE PARTICLE DESIGN | MERCK SHARP & DOHME LLC (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026104647-A1 | VACCINE | ASTRAZENECA AB (SE) | 2026-05-21 | — | — | WO | disclosed |
| US-12629412-B2 | Betacoronavirus mRNA vaccines | MODERNATX, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260130985-A1 | NUCLEIC ACID-BASED UNIVERSAL VACCINE AND METHODS OF USE THEREOF | ADVANCED RNA VACCINE ARV TECH INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-12622960-B2 | Varicella zoster virus (VZV) vaccine | MODERNATX, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260108595-A1 | BETACORONAVIRUS mRNA VACCINES | MODERNATX, INC. (US) | 2026-04-23 | — | — | US | disclosed |
| WO-1995032984-A1 | NEW LIPID ESTERS OF NUCLEOSIDE MONOPHOSPHATES AND THEIR USE AS IMMUNOSUPPRESSIVE DRUGS | BOEHRINGER MANNHEIM GMBH (DE) | 1995-12-07 | — | — | WO | disclosed |
| WO-1994006438-A1 | ADENOSINE ANALOGUES AND METHOD OF INCREASING ADENOSINE RELEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-03-31 | — | — | WO | disclosed |
| EP-0253962-B1 | USE OF ADENOSINE DERIVATIVES AS ANTI-DEMENTIA AGENTS | HOECHST JAPAN LIMITED (JP) | 1993-03-24 | — | — | EP | disclosed |
| US-5023244-A | Anti-dementia agents | HOECHST JAPAN LIMITED (JP) | 1991-06-11 | — | — | US | disclosed |
| EP-0253962-A2 | Use of adenosine derivatives as anti-dementia agents | HOECHST JAPAN LIMITED (JP) | 1988-01-27 | — | — | EP | disclosed |
| US-4225591-A | CORONARY VASODILATOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-09-30 | — | — | US | disclosed |
| JP-S5461195-A | N2-SUBSTITUTED PHENYL-2,6-DIAMINONEBULARIN | TAKEDA CHEM IND LTD | 1979-05-17 | — | — | JP | disclosed |
| US-3936439-A | VASODILATION, ANTICOAGULANTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629412-B2 | Betacoronavirus mRNA vaccines | RNMT, RNGTT, METTL16 | LMNA 616/4885NT5E 1006/4885HIF1A 4525/4885 |
| US-20260108595-A1 | BETACORONAVIRUS mRNA VACCINES | RNMT, METTL16, NSUN2 | LMNA 1182/4885NT5E 2810/4885HIF1A 4336/4885 |
| US-12622960-B2 | Varicella zoster virus (VZV) vaccine | NSUN2, RNMT, RNGTT | LMNA 1904/4885NT5E 1935/4885HIF1A 4457/4885 |
| US-20260130985-A1 | NUCLEIC ACID-BASED UNIVERSAL VACCINE AND METHODS OF USE THEREOF | UPF1, NSUN2, CD4 | LMNA 3144/4885NT5E 469/4885HIF1A 3006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.